Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.
The Fanconi anaemia (FA) FANCG protein is an integral component of the FA nuclear core complex that is required for monoubiquitylation of FANCD2. FANCG is also part of another protein complex termed D1-D2-G-X3 that contains FANCD2 and the homologous recombination repair proteins BRCA2 (FANCD1) and XRCC3. Formation of the D1-D2-G-X3 complex is mediated by serine-7 phosphorylation of FANCG and occurs independently of the FA core complex and FANCD2 monoubiquitylation. FANCG contains seven tetratricopeptide repeat (TPR) motifs that mediate protein-protein interactions and here we show that mutation of several of the TPR motifs at a conserved consensus residue ablates the in vivo binding activity of FANCG. Expression of mutated TPR1, TPR2, TPR5 and TPR6 in Chinese hamster fancg mutant NM3 fails to functionally complement its hypersensitivities to mitomycin C (MMC) and phleomycin and fails to restore FANCD2 monoubiquitylation. Using co-immunoprecipitation analysis, we demonstrate that these TPR-mutated FANCG proteins fail to interact with BRCA2, XRCC3, FANCA or FANCF. The interactions of other proteins in the D1-D2-G-X3 complex are also absent, including the interaction of BRCA2 with both the monoubiquitylated (FANCD2-L) and non-ubiquitylated (FANCD2-S) isoforms of FANCD2. Interestingly, a mutation of TPR7 (R563E), that complements the MMC and phleomycin hypersensitivity of human FA-G EUFA316 cells, fails to complement NM3, despite the mutated FANCG protein co-precipitating with FANCA, BRCA2 and XRCC3. Whilst interaction of TPR7-mutated FANCG with FANCF does appear to be reduced in NM3, FANCD2 is monoubiquitylated suggesting that sub-optimal interactions of FANCG in the core complex and the D1-D2-G-X3 complex are responsible for the observed MMC- and phleomycin-hypersensitivity, rather than a defect in FANCD2 monoubiquitylation. Our data demonstrate that FANCG functions as a mediator of protein-protein interactions and is vital for the assembly of multi-protein complexes including the FA core complex and the D1-D2-G-X3 complex.
Wilson
James B
JB
Molecular Oncology and Stem Cell Research Group, School of Biological Sciences, University of Liverpool, Biosciences Building, Crown Street, Liverpool L69 7ZB, UK.
Blom
Eric
E
Cunningham
Ryan
R
Xiao
Yuxuan
Y
Kupfer
Gary M
GM
Jones
Nigel J
NJ
D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D000818:Animals; D024682:BRCA2 Protein / Q000378:metabolism*; D016466:CHO Cells; D006224:Cricetinae; D003412:Cricetulus; D004268:DNA-Binding Proteins / Q000378:metabolism; D052236:Fanconi Anemia Complementation Group D2 Protein / Q000378:metabolism*; D052241:Fanconi Anemia Complementation Group G Protein / Q000737:chemistry*; D006801:Humans; D051379:Mice; D009154:Mutation; D019384:Nucleic Acid Synthesis Inhibitors / Q000494:pharmacology*; D010692:Phleomycins / Q000494:pharmacology*; D011995:Recombination, Genetic; D014162:Transfection; D054875:Ubiquitination
D024682:BRCA2 Protein; D004268:DNA-Binding Proteins; C499905:FANCD2 protein, human; C499909:FANCG protein, human; D052236:Fanconi Anemia Complementation Group D2 Protein; D052241:Fanconi Anemia Complementation Group G Protein; D019384:Nucleic Acid Synthesis Inhibitors; D010692:Phleomycins; C110901:X-ray repair cross complementing protein 3
Cell Signal. 2004 Aug;16(8):857-72
15157665
Carcinogenesis. 2002 Jan;23(1):67-72
11756225
Mol Cell. 2010 Mar 26;37(6):749-51
20347418
Proc Natl Acad Sci U S A. 1997 Aug 19;94(17):9232-7
9256465
J Biol Chem. 2008 Jan 11;283(2):940-50
17981804
Radiat Res. 2004 Mar;161(3):318-25
14982482
Mol Cell Biol. 2003 Aug;23(15):5421-30
12861027
Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):128-42
15668941
Mol Cell. 2007 Feb 9;25(3):331-43
17289582
Mol Cell. 2001 Jul;8(1):71-84
11511361
DNA Repair (Amst). 2004 Jan 5;3(1):77-84
14697762
Nat Genet. 1998 Nov;20(3):281-3
9806548
Front Biosci. 2008 May 01;13:4938-52
18508559
Nucleic Acids Res. 2008 Jun;36(11):3781-90
18492718
J Biol Chem. 2004 Oct 15;279(42):43910-9
15299030
Bioessays. 2004 Oct;26(10):1058-68
15382137
Mol Cell. 2006 Jun 23;22(6):719-729
16793542
Mutagenesis. 2004 May;19(3):237-44
15123790
Mutagenesis. 2009 Mar;24(2):173-81
19147795
Blood. 2008 May 15;111(10):5215-22
18174376
Mol Cell. 2001 Feb;7(2):249-62
11239454
Mutat Res. 2009 Jul 31;668(1-2):20-6
19379763
J Struct Biol. 2001 May-Jun;134(2-3):117-31
11551174
J Biol Chem. 2004 Oct 29;279(44):46035-45
15299017
Oncogene. 2008 Jun 12;27(26):3641-52
18212739
Crit Rev Biochem Mol Biol. 2009 Sep-Oct;44(5):292-325
19728769
Hum Mol Genet. 2001 Feb 15;10(4):423-9
11157805
Biochem Biophys Res Commun. 2000 Feb 5;268(1):73-7
10652215
Int J Biochem Cell Biol. 2008;40(11):2358-62
17951098
Mutat Res. 2009 Jul 31;668(1-2):11-9
19061902
Biochemistry. 2009 Jan 20;48(2):254-63
19102630
Nat Rev Genet. 2007 Oct;8(10):735-48
17768402
Somat Cell Mol Genet. 1993 Sep;19(5):431-7
8291021
Curr Opin Struct Biol. 1999 Jun;9(3):383-9
10361086
Cancer Res. 2009 Nov 15;69(22):8775-83
19861535
Hum Mol Genet. 2004 Jun 15;13(12):1241-8
15115758
Crit Rev Biochem Mol Biol. 2004 Sep-Dec;39(5-6):279-95
15763706
Cancer. 2003 Jan 15;97(2):425-40
12518367
Blood. 2003 Jul 1;102(1):136-41
12649160
DNA Repair (Amst). 2006 May 10;5(5):629-40
16621732
Nucleic Acids Res. 2007;35(5):1638-48
17308347
Trends Biochem Sci. 1995 Jul;20(7):257-9
7667876
Nat Genet. 2007 Feb;39(2):162-4
17200671
Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1110-5
15650050
Bioessays. 1999 Nov;21(11):932-9
10517866
Biochemistry. 2001 Jun 19;40(24):7025-34
11401546
EMBO J. 1998 Mar 2;17(5):1192-9
9482716
Hum Mol Genet. 2000 Nov 1;9(18):2665-74
11063725
Mutat Res. 1999 Sep 13;435(1):103-9
10526221
Hum Mol Genet. 2003 Oct 1;12(19):2503-10
12915460
Carcinogenesis. 2001 Dec;22(12):1939-46
11751423
Genes Cells. 2002 Mar;7(3):333-42
11918676
Mutat Res. 2009 Jul 31;668(1-2):54-72
19622404
Blood. 2006 Sep 15;108(6):2072-80
16720839
Science. 2002 Jul 26;297(5581):606-9
12065746
Cell Biol Int. 2006 Nov;30(11):866-78
16889989
DNA Repair (Amst). 2005 Jan 2;4(1):11-22
15533833
Genes Cells. 2007 Jul;12(7):841-51
17584296
Mutat Res. 2009 Jul 31;668(1-2):4-10
19622403
Mutat Res. 1996 Aug 8;363(3):209-21
8765162
Mutat Res. 1988 Mar;193(2):109-21
3347204
EMBO J. 2007 Apr 18;26(8):2104-14
17396147
Nat Genet. 2005 Sep;37(9):934-5
16116423
Am J Pathol. 2010 Jun;176(6):2935-47
20363922
J Biol Chem. 2000 Nov 10;275(45):34931-7
10944529
J Biol Chem. 2007 Jan 19;282(3):2047-55
17082180
Exp Hematol. 2001 Jul;29(7):842-9
11438206
Cell. 2007 Apr 20;129(2):289-301
17412408